Kyu‐Beck Lee

Metabolically Healthy Obesity and Development of Chronic Kidney Disease

Yoosoo Chang, Seungho Ryu, Yuni Choi et al. · Annals of Internal Medicine · 2016 · 278 citations

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Clinical and Angiographic Follow-up of Spontaneous Isolated Superior Mesenteric Artery Dissection

Woo‐Sung Yun, Y.W. Kim, K.B. Park et al. · European Journal of Vascular and Endovascular Surgery · 2009 · 210 citations

Interventional Neuroradiology, Vascular Surgery, Surgery +5

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Environmental Heavy Metal Exposure and Chronic Kidney Disease in the General Population

Nam Hee Kim, Young Youl Hyun, Kyu‐Beck Lee et al. · Journal of Korean Medical Science · 2015 · 187 citations · Full text

Hypertension, Metal Contamination, Medical Geochemistry +20